PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment

Overview of attention for article published in The Journal of Allergy and Clinical Immunology, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 11 X users

facebook: 2 Facebook pages
podcasts: 1 podcast

Readers on

mendeley: 51 Mendeley

So far, Altmetric has seen 1 podcast episode.

S1 Episode 2: Precision Medicine and Clinical Trials for Moderate to Severe Asthma: The Past, The Present, and The Future

Medscape InDiscussion: Moderate to Severe Asthma, 04 Aug 2022

Drs Michael Wechsler and Mario Castro discuss precision medicine for moderate to severe asthma and the past, present, and…

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.